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Résumé en
anglais
OBJECTIVE: The aim of the study was to describe the evolution of mortality and
cause-specific mortality over time in patients with systemic necrotizing vasculitides
(SNV), including polyarteritis nodosa (PAN), granulomatosis with polyangiitis
(GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with
polyangiitis (EGPA).
METHODS: Patients with SNV from the French Vasculitis Study Group registry
were divided into 5 groups according to the date of diagnosis: <1980, 1980-1989,
1990-1999, 2000-2010, and ≥ 2010. The causes of death were classified as
vasculitis, infection, cardiovascular, malignancy, miscellaneous, or unknown.
RESULTS: Among the 2217 patients included (PAN 16.1%, GPA 41.7%, EGPA
22.6%, MPA 19.6%), overall incidence of death was 2.26 per 100 person-years. The
overall survival improved during each period considered. The 5-year survival rate
increased from 72.2% (95% confidence interval [CI] 59.7-87.2) for patients
diagnosed before 1980 to 94.5% (95% CI 90.4-98.8) after 2010 (p < 0.001). Periods
of diagnosis, age, and male gender were independently associated with a poor
survival with a non-significant difference between vasculitis. The incidence of
mortality between the 1980s and after 2010 significantly decreased for vasculitis-
related (p = 0.03) and cardiovascular-related deaths (p = 0.04). Incidence of death
by infection remained stable between the 1980s and the 2000s but no death by
infection occurred after 2010. The incidence of death by malignancy remained
stable over time.
CONCLUSION: Overall survival of SNV patients has improved since the 1980s with
the decrease of vasculitis- and cardiovascular-related deaths, but cancer-related
mortality remained stable. These results highlight malignancy as the current target
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